RSS
Sitemap
Contact
About
HMA
Human Medicines
Veterinary Medicines
You are here:
Home
>
Human Medicines
>
CMDh
>
Procedural Guidance
>
Variation
>
Art 5 recommendations
CMDh
About CMDh
Statistics
Agendas and Minutes
Press Releases
BREXIT
Procedural Guidance
General Info
Application for
MA
eSubmissions
Generics
Applicant“s Responses
Renewal
Consultation with target patient groups
Variation
Art 5 recommendations
USR
Art 61.3 Procedure
Post Referral Phase
CMDh-Referrals
Product Information
Advice from CMDh
Templates
CMD Working Parties / Working Groups
Paediatric Regulation
Pharmacovigilance
Falsified Medicines
IGDRP
Questions & Answers
Contact Points
What's new history
MRI
Product Index
Pharmacovigilance
Publications and reports
National Contacts
Art.5 on Unforeseen Variations
Timetables 2017 for requests to CMDh for a recommendation on classification of an unforseen variation - Article 5
(September 2016)
CMDh Recommendation for classification of unforeseen variations according to Article 5 of Commission Regulation (
EC
) 1234/2008
(March 2017)
CMDv Recommendations for Classification of Unforeseen Variations according to Article 5 of Commission Regulation (
EC
) 1234/2008
Templates
Template of the Article 5